Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study

• Váldodahkkit: Chien-Yu Cheng (Dahkki), Ying-Shih Su (Dahkki), Chyi-Liang Chen (Dahkki), Mingi Chang (Dahkki), Shu-Wei Huang (Dahkki), Peng-Nien Huang (Dahkki), Shin-Ru Shih (Dahkki), Yu-Shen Hsu (Dahkki), Cheng-Hsun Chiu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The objective of the study was to assess the safety, tolerability, and potential efficacy of intranasally administered AD17002, a detoxified form of Escherichia coli heat-labile enterotoxin, in treating individuals with mild-to-moderate coronavirus disease of 2019 (COVID-19). In this randomized, dou...